SELENBP1 and non-small cell lung carcinoma: The expression of SELENBP1 was notably decreased in 45 out of 59 (45/59, 76.27%) human primary NSCLC tissues compared with their paired adjacent nontumor tissues (Figure 1C,D; Table S3).